Subtype
Lung Carcinoma
CI-CAN-00001086Explore in graph →
2,130 active trials51 approved drugs598 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001086Explore in graph →
Clinical trials
7,792 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,179)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02554591 | Genomic Landscape of Ceritinib | terminated | — | 6 | Washington University School of MedicineOTHER | 1 | Mar 5, 2018 | clinicaltrials |
| NCT02590003 | Single Agent Versus Combination Chemotherapy to Treat High-risk Elderly With Non-small Cell Lung Cancer | terminated | Phase 2 | 3 | Yale UniversityOTHER | 1 | Feb 28, 2018 | clinicaltrials |
| NCT02342353 |
| Pacritinib in Patients With Endothelial Growth Factor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC) After EGFR Tyrosine Kinase Inhibitor (TKI) |
| terminated |
| Phase 1 |
| 8 |
| Washington University School of MedicineOTHER |
| 1 |
| Feb 27, 2018 |
| clinicaltrials |
| NCT01090830 | Safety and Efficacy of Belinostat When Used With Standard of Care Chemotherapy for Untreated Non-small Cell Lung Cancer(HCH003) | terminated | Phase 1 / Phase 2 | 7 | Holy Cross Hospital, FloridaOTHER | 1 | Feb 23, 2018 | clinicaltrials |
| NCT02119650 | Ruxolitinib in Combination With Pemetrexed/Cisplatin in Non Small Cell Lung Cancer | terminated | Phase 2 | 76 | Incyte CorporationINDUSTRY | 1 | Feb 13, 2018 | clinicaltrials |
| NCT03053297 | Observational Study of Patients With Locally Advanced or Metastatic NSCLC (Non-Small Cell Lung Cancer)(PANORAMA) | terminated | — | 89 | AstraZenecaINDUSTRY | 6 | Feb 8, 2018 | clinicaltrials |
| NCT02393209 | Docetaxel With or Without TAK-117 (MLN1117) in Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer | terminated | Phase 1 / Phase 2 | 14 | Millennium Pharmaceuticals, Inc.INDUSTRY | 3 | Feb 7, 2018 | clinicaltrials |
| NCT00681512 | The Effect of Berries on Lung Cancer Tumors | terminated | N/A | 6 | University of LouisvilleOTHER | 1 | Feb 6, 2018 | clinicaltrials |
| NCT00003497 | Antineoplaston Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer | terminated | Phase 2 | 9 | Burzynski Research InstituteOTHER | 1 | Feb 5, 2018 | clinicaltrials |
| NCT02134015 | Study of Patritumab in Combination With Erlotinib in Subjects With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC). (HER3-Lung)(HER3-Lung) | terminated | Phase 3 | 145 | Daiichi SankyoINDUSTRY | 10 | Jan 23, 2018 | clinicaltrials |
| NCT02326285 | Induction Therapy With Intercalated Tyrosine Kinase Inhibitor (TKI) and Chemotherapy in NSCLC With Activating Epidermal Growth Factor Receptor (EGFR) Mutation in Stages II-IIIB(NeoIntercal) | terminated | Phase 2 / Phase 3 | 1 | AIO-Studien-gGmbHOTHER | 1 | Jan 23, 2018 | clinicaltrials |
| NCT01237678 | A Study of IMGN901 for Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer | terminated | Phase 1 / Phase 2 | 181 | ImmunoGen, Inc.INDUSTRY | 4 | Jan 18, 2018 | clinicaltrials |
| NCT01574222 | A Vaccine Trial for Patients With Stage IIIB, IV, or Recurrent Non-Small Cell Lung Cancer(VTNSCLC) | terminated | Phase 1 | 1 | VA Office of Research and DevelopmentFED | 1 | Jan 18, 2018 | clinicaltrials |
| NCT02018523 | Lenalidomide Maintenance Therapy in Stage IIIB/IV Non-small Cell Lung Cancer | terminated | Phase 1 | 7 | Jun ZhangOTHER | 1 | Jan 18, 2018 | clinicaltrials |
| NCT02919462 | Open-label, Multicenter, Randomized Phase II Trial of Treatment With Cisplatin and Pemetrexed or Cisplatin and Oral Vinorelbine in Chemotherapy Naïve Patients Affected by Stage IIIB-IV Non-Squamous Non-Small Cell Lung Cancer With High Thymidylate Synthase Expression(HighTySy) | terminated | Phase 2 | 2 | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCSOTHER | 1 | Jan 16, 2018 | clinicaltrials |
| NCT01261299 | Clinical Study of Microdosing Carboplatin in Lung or Bladder Cancer | terminated | Early Phase 1 | 21 | University of California, DavisOTHER | 1 | Jan 9, 2018 | clinicaltrials |
| NCT01419587 | Ketogenic Diet With Chemoradiation for Lung Cancer (KETOLUNG) | terminated | N/A | 11 | University of IowaOTHER | 1 | Jan 8, 2018 | clinicaltrials |
| NCT00369070 | A Phase 2 Trial of AMG 706 or Bevacizumab in Combination With Chemo for Advanced NSCLC | terminated | Phase 2 | 186 | AmgenINDUSTRY | 0 | Jan 4, 2018 | clinicaltrials |
| NCT01797471 | Safety of LEAD Radiotherapy Plus Chemoradiation in Patients With Bulky Stage III Non-Small Cell Lung Cancer | terminated | N/A | 1 | University of MiamiOTHER | 1 | Dec 21, 2017 | clinicaltrials |
| NCT02336061 | Evaluation of Gender Differences on the Psychosocial and Economic Impact in Patients With Advanced Non-small Cell Lung Cancer(IMPULSO) | terminated | — | 344 | Asociación para la Investigación del Cáncer de Pulmón en MujeresOTHER | 1 | Dec 15, 2017 | clinicaltrials |
| NCT00794547 | Phase I/II Calcitriol in Lung Cancer | terminated | Phase 1 / Phase 2 | 34 | University of Michigan Rogel Cancer CenterOTHER | 1 | Dec 12, 2017 | clinicaltrials |
| NCT01511081 | Stereotactic Body Radiotherapy (SBRT) Versus Stereotactic Body Proton Therapy (SBPT) | terminated | Phase 2 | 21 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 7, 2017 | clinicaltrials |
| NCT01342770 | Pioglitazone Hydrochloride in Treating Patients With Stage IA-IIIA Non-small Cell Lung Cancer | terminated | Phase 2 | 6 | National Cancer Institute (NCI)NIH | 1 | Dec 5, 2017 | clinicaltrials |
| NCT01746810 | IR-guided Ablation (IRGA) Combined With Stereotactic Ablative Radiation (SABR) for Large Lung Tumors | terminated | Phase 1 | 1 | New Mexico Cancer Research AllianceOTHER | 1 | Nov 17, 2017 | clinicaltrials |
| NCT02297087 | Next-generation Sequencing of Small Cell Lung Cancer to Identify Actionable Targets for Treatment | terminated | N/A | 12 | Western Regional Medical CenterOTHER | 1 | Nov 9, 2017 | clinicaltrials |
| NCT00932152 | Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer | terminated | Phase 2 | 3 | University of PittsburghOTHER | 1 | Oct 19, 2017 | clinicaltrials |
| NCT00003496 | Antineoplaston Therapy in Treating Patients With Recurrent or Extensive-Stage Small Cell Lung Cancer | terminated | Phase 2 | 4 | Burzynski Research InstituteOTHER | 1 | Sep 28, 2017 | clinicaltrials |
| NCT01065818 | Early Prediction of Pathology Response of Chemoradiotherapy With FLT PET | terminated | N/A | 6 | Columbia UniversityOTHER | 1 | Sep 26, 2017 | clinicaltrials |
| NCT02695290 | Afatinib in EGFR+NSCLC (Recurrent or Stage IV) - Patients With Poor Performance Status (ECOG 2 or 3) | terminated | Phase 4 | 1 | Boehringer IngelheimINDUSTRY | 1 | Sep 18, 2017 | clinicaltrials |
| NCT00881712 | Proton Therapy With Chemotherapy for Stage III Non-Small Cell Lung Cancer (LU02)(LU02) | terminated | N/A | 15 | University of FloridaOTHER | 1 | Sep 11, 2017 | clinicaltrials |
| NCT02121899 | Registry Measuring Impact of RNA Expression Testing on Treatment Decisions in Early Stage Lung Cancer and Assessing the Disease-free Survival With Long-term Follow-up (ONC006)(ONC006) | terminated | — | 44 | Myriad Genetic Laboratories, Inc.INDUSTRY | 1 | Sep 5, 2017 | clinicaltrials |
| NCT02121925 | Registry Measuring the Impact of Adding RNA Expression Testing on Referral Decisions in Early Stage Lung Cancer Patients and Assessing the Disease-free Survival With Long-term Follow-up(ONC003) | terminated | — | 227 | Myriad Genetic Laboratories, Inc.INDUSTRY | 1 | Sep 5, 2017 | clinicaltrials |
| NCT02538627 | Phase 1 Combination Study of MM-151 With MM-121, MM-141, or Trametinib | terminated | Phase 1 | 5 | Merrimack PharmaceuticalsINDUSTRY | 1 | Sep 5, 2017 | clinicaltrials |
| NCT02049151 | Tecemotide Following Concurrent Chemo-radiotherapy for Non-small Cell Lung Cancer(START2) | terminated | Phase 3 | 35 | EMD SeronoINDUSTRY | 2 | Aug 23, 2017 | clinicaltrials |
| NCT02835599 | Registry for the EVolution Of LUng Cancer Therapy Implementation and Outcomes Now(REVOLUTION) | terminated | — | 23 | AstraZenecaINDUSTRY | 1 | Aug 22, 2017 | clinicaltrials |
| NCT02715102 | Circulating Tumor DNA in Patients at High Risk for Lung Cancer | terminated | — | 39 | Pathway GenomicsINDUSTRY | 1 | Aug 21, 2017 | clinicaltrials |
| NCT00791336 | Study to Evaluate Using Nelfinavir With Chemoradiation for Non-small Cell Lung Cancer | terminated | Phase 2 | 1 | University of IowaOTHER | 1 | Jul 28, 2017 | clinicaltrials |
| NCT01575782 | Chloroquine as an Anti-autophagic Radiosensitizing Drug in Stage I-III Small Cell Lung Cancer(Chloroquine) | terminated | Phase 1 | 5 | Maastricht Radiation OncologyOTHER | 1 | Jul 18, 2017 | clinicaltrials |
| NCT00454324 | Study of Abraxane and Carboplatin to Treat Small Cell Lung Cancer(NRR) | terminated | Phase 2 | 30 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Jul 11, 2017 | clinicaltrials |
| NCT00958022 | Carboplatin and Etoposide Plus LBH589 for Small Cell Lung Cancer | terminated | Phase 1 | 7 | Ahmad TarhiniOTHER | 1 | Jun 22, 2017 | clinicaltrials |
| NCT00662311 | Vorinostat, Paclitaxel, and Radiation Therapy in Treating Patients Unable to Tolerate Cisplatin With Stage III Non-Small Lung Cancer That Cannot Be Removed By Surgery | terminated | Phase 1 / Phase 2 | 5 | University of WashingtonOTHER | 1 | Jun 14, 2017 | clinicaltrials |
| NCT00266812 | Safety and Tolerability of Low-Dose Temozolomide During Whole Brain Radiation in Patients With Cerebral Metastases From Non-Small-Cell Lung Cancer (Study P04071)(TERMINATED) | terminated | Phase 2 | 35 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Jun 8, 2017 | clinicaltrials |
| NCT00423150 | Phase 2 Study of Temozolomide in Pre-Selected Advanced Aerodigestive Tract Cancers (Study P04273AM2)(TERMINATED) | terminated | Phase 2 | 86 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Jun 8, 2017 | clinicaltrials |
| NCT00632203 | Study of Maintenance Temozolomide Versus Observation in Stable or Responding Stage III/IV Non-Small Cell Lung Cancer Patients (Study P05146) | terminated | Phase 2 | 53 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Jun 7, 2017 | clinicaltrials |
| NCT00592007 | Study Evaluating the Addition of Fulvestrant to Erlotinib in Stage IIIB/IV Non-Small Cell Lung Cancer | terminated | Phase 2 | 7 | Lyudmila Bazhenova, M.D.OTHER | 1 | Jun 6, 2017 | clinicaltrials |
| NCT00034697 | Study of Temozolomide in the Treatment of Brain Metastasis From Non-small-cell Lung Cancer (Study P02143) | terminated | Phase 2 | 24 | Merck Sharp & Dohme LLCINDUSTRY | 0 | May 23, 2017 | clinicaltrials |
| NCT00801801 | Study of Low Dose Chemotherapy Plus Sorafenib as Initial Therapy for Patients With Advanced Non-Squamous Cell NSCLC | terminated | Phase 2 | 5 | Francisco Robert,MDOTHER | 1 | May 17, 2017 | clinicaltrials |
| NCT00455572 | Cancer Immunotherapy GSK1572932A as Adjuvant Therapy for Patients With Tumor-antigen-positive Non-Small Cell Lung Cancer | terminated | Phase 1 | 71 | GlaxoSmithKlineINDUSTRY | 6 | May 15, 2017 | clinicaltrials |
| NCT02276560 | Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC(LCCC1407) | terminated | Phase 2 | 1 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | May 11, 2017 | clinicaltrials |
| NCT01719861 | Phase 2a Desipramine in Small Cell Lung Cancer and Other High-Grade Neuroendocrine Tumors | terminated | Phase 2 | 6 | Joel NealOTHER | 1 | Apr 17, 2017 | clinicaltrials |
Data updated 23 days agoSource updated Mar 5, 2018source: clinicaltrials